CH692046A5 - Derivati salini della cefalexina e loro composizioni farmaceutiche. - Google Patents

Derivati salini della cefalexina e loro composizioni farmaceutiche. Download PDF

Info

Publication number
CH692046A5
CH692046A5 CH00222/97A CH22297A CH692046A5 CH 692046 A5 CH692046 A5 CH 692046A5 CH 00222/97 A CH00222/97 A CH 00222/97A CH 22297 A CH22297 A CH 22297A CH 692046 A5 CH692046 A5 CH 692046A5
Authority
CH
Switzerland
Prior art keywords
sep
derivatives according
cel
methylol
saline
Prior art date
Application number
CH00222/97A
Other languages
English (en)
Italian (it)
Inventor
Alberto Reiner
Giorgio Reiner
Original Assignee
Apr Italia S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Apr Italia S R L filed Critical Apr Italia S R L
Publication of CH692046A5 publication Critical patent/CH692046A5/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/22—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH00222/97A 1996-02-02 1997-01-31 Derivati salini della cefalexina e loro composizioni farmaceutiche. CH692046A5 (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT96MI000183A IT1282376B1 (it) 1996-02-02 1996-02-02 Derivati salini della cefalexina e loro composizioni farmaceutiche

Publications (1)

Publication Number Publication Date
CH692046A5 true CH692046A5 (it) 2002-01-15

Family

ID=11373110

Family Applications (1)

Application Number Title Priority Date Filing Date
CH00222/97A CH692046A5 (it) 1996-02-02 1997-01-31 Derivati salini della cefalexina e loro composizioni farmaceutiche.

Country Status (3)

Country Link
KR (1) KR970061900A (OSRAM)
CH (1) CH692046A5 (OSRAM)
IT (1) IT1282376B1 (OSRAM)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6064991A (ja) * 1983-09-17 1985-04-13 Fujisawa Pharmaceut Co Ltd セファレキシン・ホスミドマイシン塩およびその製造法
KR890000642B1 (ko) * 1986-06-02 1989-03-22 윤충호 가동날개를 가진 수차

Also Published As

Publication number Publication date
IT1282376B1 (it) 1998-03-20
ITMI960183A0 (OSRAM) 1996-02-02
ITMI960183A1 (it) 1997-08-02
KR970061900A (ko) 1997-09-12

Similar Documents

Publication Publication Date Title
US20090156517A1 (en) Stable pharmaceutical compositions of aminoglycoside antibiotics, ion-chelating agents, and buffers
FI116270B (fi) Menetelmä stabiloidun prostaglandiini E1:n formulaation valmistamiseksi
CA2657773C (en) Dental compositions comprising a phosphorylated pullulan, a cationic bactericidal agent and a solvent
SE7614258L (sv) Forfarande for framstellning av kinazoloderivat
KR20000068329A (ko) 약물내성 연쇄상구균 폐렴 치료용 약제 제조시의 아목시실린 및클라불라네이트의 조합물의 용도
CH667590A5 (it) Composizione farmaceutica effervescente idrosolubile contenente n-acetil-cisteina. .
JPH03193735A (ja) グリコペプチド系抗生物質の安定化組成物
AU2009285632A1 (en) Compositions and methods of treatment comprising ceftaroline
CA2351673A1 (en) Pharmaceutical antibacterial compositions
CA1333775C (en) Injectable solutions containing pyridine derivatives
CH692046A5 (it) Derivati salini della cefalexina e loro composizioni farmaceutiche.
JP6471407B2 (ja) 口腔又は咽喉用組成物
DK146435B (da) Fremgangsmaade til fremstilling af stabilt prostaglandinholdigt, frysetoerret pulver
JP2969002B2 (ja) 固体医薬製剤の投与剤型の製造方法
ITMI941169A1 (it) Formulazioni farmaceutiche
KR102099711B1 (ko) TGF-β1 유전자의 발현을 억제하는 단일-가닥 핵산 분자를 안정적으로 함유하는 조성물
WO2011078832A1 (en) Effervescent formulations comprising cefixime
RU2349305C2 (ru) Улучшенные готовые лекарственные формы, содержащие замещенные производные имидазола
CS226153B2 (en) Method of preparing new stable neutral water-soluble complexes of tetracyclin series antibiotics
KR20090045262A (ko) 1-메틸카르바페넴 화합물의 동결 건조 제제
CA2405453A1 (en) Pharmaceutical composition containing camptothecin derivative and ph-adjusting substance
PT99447B (pt) Processo para a preparacao de composicoes anti-placa aperfeicoadas, constituidas por uma combinacao de um alcool de morfolinoamino com um agente anti-microbiano
JP2024013088A (ja) 液体口腔用組成物
US4582845A (en) Pharmaceutical composition for injection
US20210275581A1 (en) Oral Care Composition Containing Cetylpyridinium Tetrachlorozincate

Legal Events

Date Code Title Description
PFA Name/firm changed

Owner name: REAL SRL TRANSFER- APR ITALIA S.R.L.

PL Patent ceased